These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 15795127)

  • 1. Preferential downmodulation of certain chemokines by fexofenadine in human keratinocytes.
    Kobayashi M; Tokura Y
    J Dermatol Sci; 2005 Apr; 38(1):67-9. PubMed ID: 15795127
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidermal chemokines and modulation by antihistamines, antibiotics and antifungals.
    Tokura Y; Kobayashi M; Kabashima K
    Exp Dermatol; 2008 Feb; 17(2):81-90. PubMed ID: 18034836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fexofenadine: a antihistaminic. Review of its practical characteristics].
    Caballero E; Ocaña I; Azanza JR; Sádaba B
    Rev Med Univ Navarra; 1999; 43(2):93-7. PubMed ID: 11256010
    [No Abstract]   [Full Text] [Related]  

  • 4. Prolonged QTc time and ventricular arrhythmia with fexofenadine.
    Kashyap AS; Kashyap S
    Am J Cardiol; 1999 Nov; 84(10):1278-9. PubMed ID: 10569349
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibitory effects of epinastine on chemokine production and MHC class II/CD54 expression in keratinocytes.
    Kobayashi M; Kabashima K; Tokura Y
    J Dermatol Sci; 2007 Feb; 45(2):144-6. PubMed ID: 17070018
    [No Abstract]   [Full Text] [Related]  

  • 6. In vitro studies with fexofenadine, a new nonsedating histamine H1 receptor antagonist, on isolated human basophils.
    Amon U; Amon S; Gibbs BF
    Inflamm Res; 2000 Apr; 49 Suppl 1():S13-4. PubMed ID: 10864400
    [No Abstract]   [Full Text] [Related]  

  • 7. Downmodulatory effects of the antihistaminic drug bepotastine on cytokine/chemokine production and CD54 expression in human keratinocytes.
    Kobayashi M; Kabashima K; Nakamura M; Tokura Y
    Skin Pharmacol Physiol; 2009; 22(1):45-8. PubMed ID: 19088500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical pharmacology of fexofenadine in children.
    Simons FE; Bergman JN; Watson WT; Simons KJ
    J Allergy Clin Immunol; 1996 Dec; 98(6 Pt 1):1062-4. PubMed ID: 8977506
    [No Abstract]   [Full Text] [Related]  

  • 9. Fexofenadine in horses: pharmacokinetics, pharmacodynamics and effect of ivermectin pretreatment.
    Olsén L; Ingvast-Larsson C; Larsson P; Broström H; Bondesson U; Sundqvist M; Tjälve H
    J Vet Pharmacol Ther; 2006 Apr; 29(2):129-35. PubMed ID: 16515667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to Gonzalez and Estes.
    Philpot E
    Int J Clin Pharmacol Ther; 1999 Apr; 37(4):207-8. PubMed ID: 10235423
    [No Abstract]   [Full Text] [Related]  

  • 11. The proarrhythmic antihistaminic drug terfenadine increases spontaneous calcium release in human atrial myocytes.
    Hove-Madsen L; Llach A; Molina CE; Prat-Vidal C; Farré J; Roura S; Cinca J
    Eur J Pharmacol; 2006 Dec; 553(1-3):215-21. PubMed ID: 17078945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combined neurophysiological and behavioural study into the stimulating effects of fexofenadine on performance.
    Theunissen EL; Jonkman LM; Kuypers KP; Ramaekers JG
    J Psychopharmacol; 2006 Jul; 20(4):496-505. PubMed ID: 16174671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of new H1-receptor antagonists on cardiovascular system].
    Pietrzkowicz M; Grzelewska-Rzymowska I
    Pol Merkur Lekarski; 1998 Dec; 5(30):360-2. PubMed ID: 10101525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of fexofenadine and hydroxyzine on brake reaction time during car-driving with cellular phone use.
    Tashiro M; Horikawa E; Mochizuki H; Sakurada Y; Kato M; Inokuchi T; Ridout F; Hindmarch I; Yanai K
    Hum Psychopharmacol; 2005 Oct; 20(7):501-9. PubMed ID: 16086364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QT lengthening and life-threatening arrhythmias associated with fexofenadine.
    Craig-McFeely PM; Freemantle SL; Pearce GL; Shakir SA
    Br J Gen Pract; 2000 Feb; 50(451):148. PubMed ID: 10750216
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe cardiac arrhythmia on fexofenadine?
    Prescrire Int; 2000 Feb; 9(45):212. PubMed ID: 11503802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pustular exacerbation of psoriasis due to fexofenadine.
    Saraswat A; Saraswat M
    Clin Exp Dermatol; 2006 May; 31(3):477-8. PubMed ID: 16681618
    [No Abstract]   [Full Text] [Related]  

  • 18. Fexofenadine downmodulates antigen-presenting ability of murine epidermal Langerhans cells.
    Sugita K; Kabashima K; Tokura Y
    J Dermatol Sci; 2008 Jan; 49(1):88-91. PubMed ID: 17950577
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative study of some additives for the improvement of terfenadine performance.
    Ghorab M; Nada AH; Ghorab MM; Hammady TH
    Pharmazie; 2002 Nov; 57(11):772-3. PubMed ID: 12611283
    [No Abstract]   [Full Text] [Related]  

  • 20. Microbial oxidation of terfenadine and ebastine into fexofenadine and carebastine.
    Mazier C; Jaouen M; Sari MA; Buisson D
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5423-6. PubMed ID: 15454238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.